Celyad Oncology S.A. (CYAD) .
本页证实的标准:
SharesGrow 综合评分： 49/100 其中 2/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2015 | $-3.43 | $3K | $-29.11M | -970466.7% |
| 2016 | $-2.53 | $8.52M | $-23.61M | -277% |
| 2017 | $-5.86 | $3.54M | $-56.4M | -1593.1% |
| 2018 | $-3.26 | $3.12M | $-36.31M | -1165.7% |
| 2019 | $-2.29 | $6K | $-28.63M | -477200% |
| 2020 | $-1.26 | $5K | $-17.5M | -350020% |
| 2021 | $-1.70 | $0.00 | $-26.51M | - |
| 2022 | $-1.81 | $0.00 | $-40.94M | - |
| 2023 | $-0.33 | $102K | $-8.45M | -8282.4% |
| 2024 | $-0.14 | $186K | $-5.82M | -3131.2% |
